Quinoline antimalarial and immunomodulator
This page covers all Quinoline antimalarial and immunomodulator drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Lysosomal pH regulation; toll-like receptors (indirect).
Targets
Lysosomal pH regulation; toll-like receptors (indirect)
Marketed (1)
- Hydroxychloroquine Sulfate Regular dose · Government of Punjab, Specialized Healthcare and Medical Education Department · Immunology, Rheumatology, Infectious Disease
Hydroxychloroquine is a quinoline antimalarial and immunomodulatory agent that inhibits lysosomal function and reduces inflammatory cytokine production.
Patent intelligence
- quinoline antimalarial and immunomodulator patent landscape — aggregated cliff calendar, attackable patents, originator estates